Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2003 Jan 28;2(3):147–248. doi: 10.1016/0098-2997(79)90005-0

The scientific basis of multiple sclerosis

MLouise Cuzner 1, Alan N Davison 1
PMCID: PMC7127651

The content is available as a PDF (5.8 MB).

References

  • 1.Adams R.D., Sidman R.L. Introduction to Neuropathology. McGraw-Hill; New York: 1968. pp. 149–170. [Google Scholar]
  • 2.Adams C.W.M. Pathology of multiple sclerosis: progression of the lesion. Brit. Med. Bull. 1977;33:15–20. doi: 10.1093/oxfordjournals.bmb.a071388. [DOI] [PubMed] [Google Scholar]
  • 3.Acheson E.D. Epidemiology of multiple sclerosis. Brit. Med. Bull. 1977;33:9–14. doi: 10.1093/oxfordjournals.bmb.a071407. [DOI] [PubMed] [Google Scholar]
  • 4.Dean G., Kurtzke J.F. On the risk of multiple sclerosis according to age at immigration to South Africa. Brit. Med. J. 1971;3:725–729. doi: 10.1136/bmj.3.5777.725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Dean G., Brady R., McLoughlin H., Eliar M., Adelstein A.A. Motor neuron disease and MS among immigrants to Britain. Brit. J. Prev. Soc. Med. 1977;31:141–147. doi: 10.1136/jech.31.3.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Crain S.M., Borstein M.B. Depression of complex bioelectric discharges in cerebral tissue cultures by thermolabile complement-dependent serum factors. Exp. Neurol. 1975;49:330–335. doi: 10.1016/0014-4886(75)90216-2. [DOI] [PubMed] [Google Scholar]
  • 7.McAlpine D., Lumsden C.E., Acheson E.D. Churchill Livingstone; London: 1972. Multiple Sclerosis. A Reappraisal. [Google Scholar]
  • 8.McDonald W.I., Halliday A.M. Diagnosis and classification of multiple sclerosis. Brit. Med. Bull. 1977;33:4–8. [PubMed] [Google Scholar]
  • 9.Stoof J.C., Vrijmoed-De Vries M.C., Koetsier J.C., Langevoort H.L. Evaluation of the red blood cell cytopherometric test for the diagnosis of multiple sclerosis. Acta Neurol. Scand. 1977;56:170–176. doi: 10.1111/j.1600-0404.1977.tb01421.x. [DOI] [PubMed] [Google Scholar]
  • 10.Millar J.H.D. Thomas; Springfield, Ill: 1971. Multiple Sclerosis: a disease acquired in childhood. [Google Scholar]
  • 11.Terasaki P.I., McClelland J.D. Microdroplet assay of human serum cytotoxins. Nature. 1964;204:998–1000. doi: 10.1038/204998b0. [DOI] [PubMed] [Google Scholar]
  • 12.Bach F.H., Hirschhorn K. Lymphocyte interactions: a potential histocompatibility test in vitro. Science. 1964;143:813–814. doi: 10.1126/science.143.3608.813. [DOI] [PubMed] [Google Scholar]
  • 13.Lamm L.U., Thorsen I-U., Petersen G.B., Jorgensen J., Henningsen I.C., Bech B., Igssmeyer-Nielsen F. Data on the HL-A linkage group. Annals of Human Genetics. 1975;38:383–390. doi: 10.1111/j.1469-1809.1975.tb00628.x. [DOI] [PubMed] [Google Scholar]
  • 14.Svejgaard A., Hauge M., Jersild C., Platz P., Ryder L.P., Staub Nielsen L., Thomsen M. 2nd Edition. Vol. 7. Karger; Basel: 1975. The HLA system. (Monographs in Human Genetics). [Google Scholar]
  • 15.Bodmer W.F., Batchelor J.R., Morris P.J., Festenstein H., Bodmer J.G., editors. Histocompatibility Testing 1977. Munksgaard; Copenhagen: 1978. [Google Scholar]
  • 16.Pirskanen R. Genetic association between myasthenia gravis and the HL-A system. J. Neurol. Neurosurg. & Psych. 1976;39:23–33. doi: 10.1136/jnnp.39.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.J.M. Newsom Davis, A. Vincent, D.A.S. Compston and J.R. Batchelor, in preparation.
  • 18.Compston D.A.S., Batchelor J.R., McDonald W.I. B lymphocyte alloantigens associated with multiple sclerosis. Lancet. 1976;ii:1261–1265. doi: 10.1016/s0140-6736(76)92027-4. [DOI] [PubMed] [Google Scholar]
  • 19.Terasaki P.I., Park M.S., Opelz G., Ting A. Multiple sclerosis and high incidence of a B lymphocyte alloantigen. Science. 1976;193:1245–1247. doi: 10.1126/science.1085490. [DOI] [PubMed] [Google Scholar]
  • 20.Kurdi A., Ayesh I., Abdallat A., McDonal W.I., Compston D.A.S., Batchelor J.R. Different B lymphocyte alloantigens associated with multiple sclerosis in Arbas and North Europeans. Lancet. 1977;I:1123–1125. doi: 10.1016/s0140-6736(77)92383-2. [DOI] [PubMed] [Google Scholar]
  • 1.Yakovlen P., Lecours A.R. The myelogenetic cycles of regional maturation of the brain. In: Minkowski A., editor. Regional Development of the Brain in Early Life. Blackwell; Oxford: 1967. pp. 3–64. [Google Scholar]
  • 2.Bunge M.B., Bunge R.P., Pappas G.D. Electron microscopic demonstration of connections between glia and myelin sheaths in the developing mammalian central nervous system. J. Cell. Biol. 1962;12:448–453. doi: 10.1083/jcb.12.2.448. [DOI] [PubMed] [Google Scholar]
  • 3.Peters A., Vaughn J.E. Morphology and development of the myelin sheath. In: Davison A.N., Peters A., editors. Myelination. Charles C. Thomas; Springfield, Ill: 1970. pp. 3–79. [Google Scholar]
  • 4.Autilio L.A., Norton W.T., Terry R.D. The preparation and some properties of purified myelin from the central nervous system. J. Neurochem. 1964;11:17–27. doi: 10.1111/j.1471-4159.1964.tb06719.x. [DOI] [PubMed] [Google Scholar]
  • 5.Horrocks L.A. Composition of mouse brain myelin during development. J. Neurochem. 1968;15:483–488. doi: 10.1111/j.1471-4159.1968.tb08945.x. [DOI] [PubMed] [Google Scholar]
  • 6.Cuzner M.L., Davison A.N., Gregson N.A. The chemical composition of vertebrate myelin and microsomes. J. Neurochem. 1965;12:469–481. doi: 10.1111/j.1471-4159.1965.tb06774.x. [DOI] [PubMed] [Google Scholar]
  • 7.Norton W.T. Isolation and characterization of myelin. In: Morell P., editor. Myelin. Plenum Press; N.Y. and London: 1977. pp. 161–199. [Google Scholar]
  • 8.Norton W.T., Poduslo S.E. Myelination in rat brain: changes in myelin composition during brain maturation. J. Neurochem. 1973;21:759–773. doi: 10.1111/j.1471-4159.1973.tb07520.x. [DOI] [PubMed] [Google Scholar]
  • 9.Eichberg J., Dawson R.M.C. Polyphosphoinositides in myelin. Biochem. J. 1965;96:644–650. doi: 10.1042/bj0960644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Suzuki K., Poduslo J.F., Poduslo S.E. Further evidence for a specific ganglioside fraction closely associated with myelin. Biochim. Biophys. Acta. 1968;152:576–586. doi: 10.1016/0005-2760(68)90098-2. [DOI] [PubMed] [Google Scholar]
  • 11.Ledeen R.W., Yu R.K., Eng L.F. Gangliosides of human myelin: sialosylgalactosylceramide (G7) as a major component. J. Neurochem. 1973;21:829–840. doi: 10.1111/j.1471-4159.1973.tb07527.x. [DOI] [PubMed] [Google Scholar]
  • 12.Eylar E.H., Thompson M. Allergic encephalomyelitis: the physicochemical properties of the basic protein encephalitogen from bovine spinal cord. Arch. Biochem. Biophys. 1969;129:468–479. doi: 10.1016/0003-9861(69)90204-5. [DOI] [PubMed] [Google Scholar]
  • 13.Epard R.M., Moscarello M.A., Zierenberg B., Vail W.J. The folded conformation of the encephalitogenic protein of the human brain. Biochemistry. 1974;13:1264–1267. doi: 10.1021/bi00703a032. (Easton) [DOI] [PubMed] [Google Scholar]
  • 14.Liebes L.F., Zand R., Phillips W.D. Solution behaviour, circular dichroism and 22 HMz PMR studies of the bovine myelin basic protein. Biochim. Biophys. Acta. 1975;405:27–39. doi: 10.1016/0005-2795(75)90311-6. [DOI] [PubMed] [Google Scholar]
  • 15.Jones A.J.S., Rumsby M.G. The intrinsic fluorescence characteristics of the myelin basic protein. J. Neurochem. 1975;25:565–572. doi: 10.1111/j.1471-4159.1975.tb04369.x. [DOI] [PubMed] [Google Scholar]
  • 16.Carnegie P.R., Dunkley P.R. Basic proteins of central and peripheral nervous system myelin. In: Agranoff B.W., Aprison M.H., editors. 2nd Edition. Vol. 1. Plenum Press; N.Y: 1975. pp. 95–135. (Adv. Neurochem.). [Google Scholar]
  • 17.Braun P.E., Brostoff S.W. Proteins of myelin. In: Morell P., editor. Myelin. Plenum Press; N.Y. and London: 1977. pp. 201–231. [Google Scholar]
  • 18.Smith M.E. The role of proteolytic enzymes in demyelination in experimental allergic encephalomyelitis. Neurochemical Research. 1977;2:233–246. doi: 10.1007/BF00969354. [DOI] [PubMed] [Google Scholar]
  • 19.Carnegie P.R. Amino acid sequence of the encephalitogenic basic protein from human myelin. Biochem. J. 1971;123:57–67. doi: 10.1042/bj1230057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Hashim G. Myelin basic protein: structure, function and antigenic determinants. Immunol. Rev. 1978;39:60–107. doi: 10.1111/j.1600-065x.1978.tb00397.x. [DOI] [PubMed] [Google Scholar]
  • 21.Davison A.N., Cuzner M.L. Immunochemistry and biochemistry of myelin. Brit. Med. Bull. 1977;33:60–66. doi: 10.1093/oxfordjournals.bmb.a071398. [DOI] [PubMed] [Google Scholar]
  • 22.Hashim G.A., Sharpe R.D., Carvalho E., Stevens L.E. 2nd Edition. Vol. 149. 1975. The development of experimental allergic encephalomyelitis with immunizing doses of myelin basic protein; pp. 645–651. (Proc. Soc. Exp. Biol. Med.). [DOI] [PubMed] [Google Scholar]
  • 23.Kies M.W., Driscoll B.F., Seil F.J., Alvord E.C. Myelination inhibition factor, dissociation from induction of experimental allergic encephalomyelitis. Science. 1973;179:689–690. doi: 10.1126/science.179.4074.689. [DOI] [PubMed] [Google Scholar]
  • 24.Chan D.S., Lees M.B. Gel electrophoresis studies of bovine brain white matter proteolipid and myelin proteins. Biochemistry. 1974;13:2704–2712. doi: 10.1021/bi00710a008. [DOI] [PubMed] [Google Scholar]
  • 25.Crang A.J., Rumsby M.B. Molecular organization in central nerve myelin. In: Palo J., editor. 2nd Edition. Vol. 100. Plenum Press; 1978. pp. 235–248. (Myelination and Demyelination, Advances in Experimental Medicine and Biology). [DOI] [PubMed] [Google Scholar]
  • 26.Nicot C., Nguyenhe T., Lepretre M., Alfsen A. Study of Folch-Pi apoprotein I. Isolation of two components, aggregation during delipidation. Biochim. Biophys. Acta. 1973;322:109–123. doi: 10.1016/0005-2795(73)90181-5. [DOI] [PubMed] [Google Scholar]
  • 27.Lees M.B., Messinger B.F., Burnham J.D. Tryptic hydrolysis of brain proteolipid. Biochem. Biophys. Res. Comm. 1967;28:185–190. doi: 10.1016/0006-291x(67)90427-5. [DOI] [PubMed] [Google Scholar]
  • 28.Lees M.B., Chan D.S. Proteolytic digestion of bovine brain white matter proteolipid. J. Neurochem. 1975;25:595–600. doi: 10.1111/j.1471-4159.1975.tb04373.x. [DOI] [PubMed] [Google Scholar]
  • 29.Wolfgram F. A new proteolipid fraction of the nervous system — I. Isolation and amino acid analyses. J. Neurochem. 1966;13:461–470. doi: 10.1111/j.1471-4159.1966.tb09859.x. [DOI] [PubMed] [Google Scholar]
  • 30.Morell P., Greenfield S., Costantino-Ceccarini E., Wisniewski H. Changes in the protein composition of mouse brain myelin during development. J. Neurochem. 1972;19:2545–2554. doi: 10.1111/j.1471-4159.1972.tb01313.x. [DOI] [PubMed] [Google Scholar]
  • 31.Quarles R.H., Everly J.L., Brady R.O. Evidence for the close association of a glycoprotein with myelin in rat brain. J. Neurochem. 1973;21:1177–1191. doi: 10.1111/j.1471-4159.1973.tb07573.x. [DOI] [PubMed] [Google Scholar]
  • 32.Poduslo J.F. The molecular architecture of myelin: identification of the external surface membrane components. In: Palo J., editor. 2nd Edition. Vol. 100. Plenum Press; 1978. pp. 189–205. (Myelination and Demyelination, Advances in Experimental Medicine and Biology). [DOI] [PubMed] [Google Scholar]
  • 33.Brenkert A., Radin N.S. Synthesis of galactocerebroside and glucocerebroside by rat brain: assay procedures and changes with age. Brain Res. 1972;36:183–193. doi: 10.1016/0006-8993(72)90774-3. [DOI] [PubMed] [Google Scholar]
  • 34.Costantino-Ceccarini E., Morell P. Biosynthesis of brain sphingolipids and myelin accumulation in the mouse. Lipids. 1972;7:656–659. doi: 10.1007/BF02533072. [DOI] [PubMed] [Google Scholar]
  • 35.Fry J.M., Weissbarth S., Lehrer G.M., Bornstein M.B. Cerebroside antibody inhibits sulphatide synthesis and myelination and demyelinates in cord tissue cultures. Science. 1974;183:540–542. doi: 10.1126/science.183.4124.540. [DOI] [PubMed] [Google Scholar]
  • 36.Benjamins J.A., Guarnieri M., Sonnebron M., McKhann G.M. Sulphatide synthesis in isolated oligodendroglial and neuronal cells. J. Neurochem. 1974;23:751–757. doi: 10.1111/j.1471-4159.1974.tb04400.x. [DOI] [PubMed] [Google Scholar]
  • 37.Jones J.P., Rios A., Nicholas H.J., Ramsey R.B. The biosynthesis of cholesterol and other sterols in brain tissue: distribution in subcellular fractions as a function of time after injection of [2-14C] acetate and [U-14C] glucose into 15 day old rats. J. Neurochem. 1975;24:117–121. doi: 10.1111/j.1471-4159.1975.tb07636.x. [DOI] [PubMed] [Google Scholar]
  • 38.Salway J.G., Harwood J.L., Kai M., White G.L., Hawthorne J.N. Enzymes of phosphoinositide metabolism during rat brain development. J. Neurochem. 1968;15:221–226. doi: 10.1111/j.1471-4159.1968.tb06200.x. [DOI] [PubMed] [Google Scholar]
  • 39.Ansell G.B. Phospholipids in the nervous system. In: Ansell G.B., Dawson R.M.C., Hawthorne J.N., editors. 2nd Edition. Vol. 3. BBA Library, Elsevier; N.Y: 1973. pp. 377–422. (Form and Function of Phospholipids). [Google Scholar]
  • 40.Herschkowitz N., McKham G.M., Saxena S., Shooter E.M. Characterization of sulphatide-containing lipoproteins in rat brain. J. Neurochem. 1968;15:1181–1188. doi: 10.1111/j.1471-4159.1968.tb06835.x. [DOI] [PubMed] [Google Scholar]
  • 41.Benjamins J.A., McKhann G.M. Properties and metabolism of soluble lipoproteins containing choline and ethanolamine phospholipids in rat brain. J. Neurochem. 1973;20:1121–1129. doi: 10.1111/j.1471-4159.1973.tb00082.x. [DOI] [PubMed] [Google Scholar]
  • 42.Wirtz K.W.A., Jolles J., Westerman J., Neys F. Phospholipid exchange proteins in synaptosome and myelin from rat brain. Nature. 1976;260:354–355. doi: 10.1038/260354a0. [DOI] [PubMed] [Google Scholar]
  • 43.Benjamins J.A., Jones M., Morell P. Appearance of newly synthesized protein in myelin of young rats. J. Neurochem. 1975;24:1117–1122. doi: 10.1111/j.1471-4159.1975.tb03886.x. [DOI] [PubMed] [Google Scholar]
  • 44.Smith M.E., Hasinoff C.M. Biosynthesis of myelin proteins in vitro. J. Neurochem. 1971;18:739–747. doi: 10.1111/j.1471-4159.1971.tb12004.x. [DOI] [PubMed] [Google Scholar]
  • 45.Cuzner M.L., Davison A.N. The lipid composition of rat brain myelin and subcellular fractions during development. Biochem. J. 1968;106:29–34. doi: 10.1042/bj1060029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Agrawal H.C., Banik N.L., Bone A.H., Davison A.N., Mitchell R.F., Spohn M. The identity of a myelin-like fraction isolated from developing brain. Biochem. J. 1970;120:635–642. doi: 10.1042/bj1200635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Davison A.N. The biochemistry of the myelin sheath. In: Davison A.N., Peters A., editors. Myelination. Charles C. Thomas; Springfield, Ill: 1970. pp. 80–161. [Google Scholar]
  • 48.Cuzner M.L., Davison A.N., Gregson N.A. Turnover of brain mitochondrial membrane lipids. Biochem. J. 1966;101:618–626. doi: 10.1042/bj1010618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Rawlins F.A., Villegas G.M., Uzman B.G. Myelin. In: Jamieson G.A., Robinson D.M., editors. 2nd Edition. Vol. 2. Butterworths; London: 1977. pp. 266–297. (Mammalian Cell Membranes). [Google Scholar]
  • 50.Smith M.E. The turnover of myelin in the adult rat. Biochim. Biophys. Acta. 1968;164:285–293. doi: 10.1016/0005-2760(68)90154-9. [DOI] [PubMed] [Google Scholar]
  • 51.Jungalwala F.B., Dawson R.M.C. The turnover of myelin phospholipids in the adult and developing rat brain. Biochem. J. 1971;123:683–693. doi: 10.1042/bj1230683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Benjamins J.A., Smith M.E. Metabolism of myelin. In: Morell P., editor. Myelin. Plenum Press; N.Y: 1977. pp. 233–265. [Google Scholar]
  • 53.Spohn M., Davison A.N. Cholesterol metabolism in myelin and other subcellular fractions of rat brain. J. Lipid Res. 1972;13:563–570. [PubMed] [Google Scholar]
  • 54.Banik N.L., Davison A.N. Desmosterol in rat brain myelin. J. Neurochem. 1967;14:584–595. doi: 10.1111/j.1471-4159.1967.tb09561.x. [DOI] [PubMed] [Google Scholar]
  • 55.Banik N.L., Davison A.N. Exchange of sterols between myelin and other membranes of developing rat brain. Biochem. J. 1971;122:751–758. doi: 10.1042/bj1220751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Miller E.K., Dawson R.M.C. Exchange of phospholipids between brain membranes in vitro. Biochem. J. 1972;126:823–835. doi: 10.1042/bj1260823. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.O'Brien J.S., Sampson E.L. Lipid composition of the normal human brain: gray matter, white matter and myelin. J. Lipid Res. 1965;6:537–544. [PubMed] [Google Scholar]
  • 58.Poduslo S.E., Norton W.T. Isolation and some chemical properties of oligodendroglia from calf brain. J. Neurochem. 1972;19:727–736. doi: 10.1111/j.1471-4159.1972.tb01388.x. [DOI] [PubMed] [Google Scholar]
  • 59.De Vries G.H., Norton W.T. The lipid composition of axons from bovine brain. J. Neurochem. 1974;22:259–264. doi: 10.1111/j.1471-4159.1974.tb11588.x. [DOI] [PubMed] [Google Scholar]
  • 1.Bignami A., Eng L.F. Biochemical studies of myelin in Wallerian degeneration of rat optic nerve. J. Neurochem. 1973;20:165–173. doi: 10.1111/j.1471-4159.1973.tb12113.x. [DOI] [PubMed] [Google Scholar]
  • 2.Cook R.D., Wisniewski H.M. The role of oligodendroglia and astroglia in Wallerian degeneration of the optic nerve. Brain Res. 1973;61:191–206. doi: 10.1016/0006-8993(73)90527-1. [DOI] [PubMed] [Google Scholar]
  • 3.Smith M.E. Studies on the mechanism of demyelination: triethyl tin-induced demyelination. J. Neurochem. 1973;21:357–372. doi: 10.1111/j.1471-4159.1973.tb04256.x. [DOI] [PubMed] [Google Scholar]
  • 4.McDonald W.I. Experimental neuropathology — the use of diphtheria toxin. In: Desmedt J.E., editor. 2nd Edition. Vol. 2. Karger; Basel: 1973. pp. 128–144. (New Developments in Electromyography and Clinical Neurophysiology). [Google Scholar]
  • 5.McDonald W.I., Sears T.A. Focal experimental demyelination in the central nervous system. Brain. 1970;93:575–582. doi: 10.1093/brain/93.3.575. [DOI] [PubMed] [Google Scholar]
  • 6.Pleasure D.E., Feldmann B., Prockop D.J. Diphtheria toxin inhibits the synthesis of myelin proteolipid and basic proteins by peripheral nerve in vitro. J. Neurochem. 1973;20:81–90. doi: 10.1111/j.1471-4159.1973.tb12106.x. [DOI] [PubMed] [Google Scholar]
  • 7.Wisniewski H.M. Patterns of myelin damage resulting from inflammatory and toxin-induced lesions and their relationship to multiple sclerosis. In: Wolfgram F., Ellison G.W., Stevens J.G., Andrews J.M., editors. Multiple Sclerosis: Immunology, Virology and Ultrastructure. Academic Press; N.Y. and London: 1972. pp. 53–89. [Google Scholar]
  • 8.McMartin D.N., Koestner A., Long J.F. Enzyme activities associated with the demyelinating phase of canine distemper. I. Beta-glucuronidase, acid and neutral proteinase. Acta Neuropathol. 1972;22:275–287. doi: 10.1007/BF00809239. [DOI] [PubMed] [Google Scholar]
  • 9.McMartin D.N., Horrocks L.A., Koestner A. Enzyme activities associated with the demyelinating phase of canine distemper. II. Plasmalogenase. Acta Neuropathol. 1972;22:288–294. doi: 10.1007/BF00809240. [DOI] [PubMed] [Google Scholar]
  • 10.Bowen D.M., Flack R.H.A., Martin R.O., Smith C.B., White P., Davison A.N. Biochemical studies on degenerative neurological disorders: (I) Acute experimental encephalitis. J. Neurochem. 1974;22:1099–1107. doi: 10.1111/j.1471-4159.1974.tb04342.x. [DOI] [PubMed] [Google Scholar]
  • 11.Tanaka R., Iwasaki Y., Koprowski H. Experimental parainfluenza-type 1-virus-induced encephalopathy in the adult mouse: an ultrastructural study of early lesions. Am. J. Pathol. 1975;79:537–553. [PMC free article] [PubMed] [Google Scholar]
  • 12.Suckling A.J., Webb H.E., Chew-lim M., Oates S.W. Effect of an inapparent viral encephalitis on the levels of lysosomal glycosidases in mouse brain. J. Neurol. Sci. 1976;29:109–116. doi: 10.1016/0022-510x(76)90084-8. [DOI] [PubMed] [Google Scholar]
  • 13.Suckling A.J., Jagelman S., Webb H.E. A comparison of brain lysosomal enzyme activities in four experimental togavirus encephalitides. J. Neurol. Sci. 1978;35:355–364. doi: 10.1016/0022-510x(78)90015-1. [DOI] [PubMed] [Google Scholar]
  • 14.Bignami A., Parry H.B. Electron microscopic studies of the brain of sheep with natural scrapie. I. The fine structure of neuronal vacuolation. Brain. 1972;95:319–326. doi: 10.1093/brain/95.2.319. [DOI] [PubMed] [Google Scholar]
  • 15.Porter D.D., Porter H.G., Cox N.A. Failure to demonstrate a humoral immune response to scrapie infection in mice. J. Immunol. 1975;111:1407–1410. [PubMed] [Google Scholar]
  • 16.Licursi P.C., Merz P.A., Merz G.S., Carp R.I. Scrapie-induced changes in the percentage of polymorphonuclear neutrophils in mouse peripheral blood. Infect. Immun. 1972;6:370–376. doi: 10.1128/iai.6.3.370-376.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Carp R.I., Licursi P.C., Merz P.A., Merz G.S. Decreased percentage of polymorphonuclear neutrophils in mouse peripheral blood after inoculation with material from multiple sclerosis patients. J. Exp. Med. 1972;136:618–629. doi: 10.1084/jem.136.3.618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Koldovsky U., Koldovsky P., Henle G., Henle W., Ackermann R., Haase G. Multiple sclerosis-associated agent: transmission to animals and some properties of the agent. Infect. Immun. 1975;12:1355–1366. doi: 10.1128/iai.12.6.1355-1366.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Millson G.C., Bountiff L. Glycosidases in normal and scrapie mouse brain. J. Neurochem. 1973;20:541–546. doi: 10.1111/j.1471-4159.1973.tb12153.x. [DOI] [PubMed] [Google Scholar]
  • 20.Johnson R.T. Virological data supporting the viral hypothesis in multiple sclerosis. In: Davison A.N., Humphrey J.H., Liversedge L.A., McDonald W.I., Porterfield J.S., editors. Multiple Sclerosis Research. HMSO; London: 1975. pp. 155–183. (Proceedings of a joint conference held by the Medical Research Council and the Multiple Sclerosis Society of Great Britain & Northern Ireland, 17–18 October 1974) [Google Scholar]
  • 21.Prineas J.W., Wright R.T. The fine structure of peripheral nerve lesions in a virus-induced demyelinating disease in fowl (Marek's disease) Lab. Invest. 1972;26:548–557. [PubMed] [Google Scholar]
  • 22.Hall S.M., Gregson N.A. The in vivo and ultrastructural effects of injection of lysophosphatidyl choline into myelinated peripheral nerve fibres of the adult mouse. J. Cell Sci. 1971;9:769–789. doi: 10.1242/jcs.9.3.769. [DOI] [PubMed] [Google Scholar]
  • 23.Blakemore W.F., Eames R.A., Smith K.J., McDonald W.I. Remyelination in the spinal cord of the cat following intraspinal injections of lysolecithin. J. Neurol. Sci. 1977;33:31–43. doi: 10.1016/0022-510x(77)90179-4. [DOI] [PubMed] [Google Scholar]
  • 24.Peterson R.G. Electron microscopy of trypsin-digested peripheral nerve myelin. J. Neurocytol. 1975;4:115–120. doi: 10.1007/BF01099099. [DOI] [PubMed] [Google Scholar]
  • 25.Peterson R.G. Myelin protein changes with digestion of whole sciatic nerve in trypsin. Life Sci. 1976;18:845–850. doi: 10.1016/0024-3205(76)90011-4. [DOI] [PubMed] [Google Scholar]
  • 26.Coles E., McIlwain D.L., Rapport M.M. The activity of pure phospholipase A2 from Crotalus atrox venom on myelin and on pure phospholipids. Biochim. Biophys. Acta. 1974;337:68–78. doi: 10.1016/0005-2760(74)90041-1. [DOI] [PubMed] [Google Scholar]
  • 27.Banik N.L., Gohil K., Davison A.N. The action of snake venom, phospholipase A and trypsin on purified myelin in vitro. Biochem. J. 1976;159:273–277. doi: 10.1042/bj1590273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Schäfer R., Franklin R.M. Resistance of the basic membrane proteins of myelin and bacteriophage PM2 to proteolytic enzymes. FEBS Lett. 1975;58:265–268. doi: 10.1016/0014-5793(75)80275-4. [DOI] [PubMed] [Google Scholar]
  • 29.Saito M., Nagai Y., Tsumita T. A novel method for the extraction of encephalitogenic protein from brain. Jap. J. Exp. Med. 1972;42:473–481. [PubMed] [Google Scholar]
  • 30.London Y., Vossenberg F.G.A. Specific interaction of central nervous system myelin basic protein with lipids: specific regions of the protein sequence protected from the proteolytic action of trypsin. Biochim. Biophys. Acta. 1973;307:478–490. doi: 10.1016/0005-2736(73)90295-2. [DOI] [PubMed] [Google Scholar]
  • 31.Cohen S.R., McKhann G.M., Guarnieri M. A radioimmunoassay for myelin basic protein and its use for quantitative measurements. J. Neurochem. 1975;25:371–376. doi: 10.1111/j.1471-4159.1975.tb04329.x. [DOI] [PubMed] [Google Scholar]
  • 32.Marks N., Benuck M., Hashim G. Hydrolysis of myelin basic protein with brain acid proteinase. Biochem. Biophys Res. Comm. 1974;56:68–74. doi: 10.1016/s0006-291x(74)80316-5. [DOI] [PubMed] [Google Scholar]
  • 33.Benuck M., Marks N., Hashim G. Brain cathepsin D induced release of encephalitogenic fragments from myelin basic protein. Eur. J. Biochem. 1975;52:615–621. doi: 10.1111/j.1432-1033.1975.tb04033.x. [DOI] [PubMed] [Google Scholar]
  • 34.M.L. Cuzner, unpublished observations.
  • 35.Bowen D.M., Davison A.N. Macrophages and cathepsin A activity in multiple sclerosis brain. J. Neurol. Sci. 1974;21:227–231. doi: 10.1016/0022-510x(74)90074-4. [DOI] [PubMed] [Google Scholar]
  • 36.Marks N., Grynbaum A., Benuck M. On the sequential cleavage of myelin basic protein by cathepsin A and D. J. Neurochem. 1976;27:765–768. doi: 10.1111/j.1471-4159.1976.tb10405.x. [DOI] [PubMed] [Google Scholar]
  • 37.Röyttä M., Frey H., Riekkinen P.J., Laaksonen H., Rinne U.K. Myelin breakdown and basic protein. Experimental Neurology. 1974;45:174–185. doi: 10.1016/0014-4886(74)90109-5. [DOI] [PubMed] [Google Scholar]
  • 38.Marks N., Grynbaum A., Lajtha A. The breakdown of myelin-bound proteins by intra- and extra-cellular proteases. Neurochem. Res. 1976;1:93–111. doi: 10.1007/BF00965635. [DOI] [PubMed] [Google Scholar]
  • 39.Steck A.J., Siegrist P., Herschkowitz N. Phosphorylation of myelin basic protein by vaccinia virus cores. Nature. 1976;263:436–438. doi: 10.1038/263436a0. [DOI] [PubMed] [Google Scholar]
  • 40.Cammer W., Bloom B.R., Norton W.T., Gordon S. 2nd Edition. Vol. 75. 1978. Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination; pp. 1554–1558. (Proc. Natl. Acad. Sci. (USA)). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Smith M.E. A lymph node neutral proteinase acting on myelin basic protein. J. Neurochem. 1976;27:1077–1082. doi: 10.1111/j.1471-4159.1976.tb00311.x. [DOI] [PubMed] [Google Scholar]
  • 1.Paterson P.Y. Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J. Exp. Med. 1960;111:119–136. doi: 10.1084/jem.111.1.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Paterson P.Y. Experimental autoimmune (allergic) encephalomyelitis: induction, pathogenesis and suppression. In: Miescher P.A., Mulley E.H., editors. 2nd Edition. 1976. pp. 179–213. (Textbook of Immunopathology). [Google Scholar]
  • 3.Levine S., Wenk E.J. A hyperacute form of allergic encephalomyelitis. Am. J. Pathol. 1965;47:61–88. [PMC free article] [PubMed] [Google Scholar]
  • 4.Stone S.H., Lerner E.M. Chronic disseminated allergic encephalomyelitis in inbred guinea pigs. Ann. N.Y. Acad. Sci. 1965;122:227–241. doi: 10.1111/j.1749-6632.1965.tb20206.x. [DOI] [PubMed] [Google Scholar]
  • 5.Raine C.S., Snyder D.H., Valsamis M.P., Stone S.H. Chronic experimental allergic encephalomyelitis in inbred guinea pigs — an ultrastructural study. Lab. Invest. 1974;31:369–380. [PubMed] [Google Scholar]
  • 6.Wisniewski H.M., Keith A.B. Chronic relapsing experimental allergic encephalomyelitis: an experimental model of multiple sclerosis. Ann. Neurol. 1977;1:144–148. doi: 10.1002/ana.410010207. [DOI] [PubMed] [Google Scholar]
  • 7.Paterson P.Y. Vol. 35. 1976. Experimental allergic encephalomyelitis: role of fibrin deposition in immunopathogenesis of inflammation in rats; pp. 2428–2434. (Fedn. Proc.). [PubMed] [Google Scholar]
  • 8.Leibowitz S., Kennedy L. Cerebral vascular permeability and cellular infiltration in experimental allergic encephalomyelitis. Immunology. 1972;22:859–869. [PMC free article] [PubMed] [Google Scholar]
  • 9.Waksman B.H., Adams R.D. A histological study of the early lesion in experimental allergic encephalomyelitis in the guinea pig and rabbit. Am. J. Pathol. 1962;41:135–162. [PMC free article] [PubMed] [Google Scholar]
  • 10.Bubis J.J., Luse S.A. Ultrastructural of the leptomeninges in experimental allergic encephalomyelitis. Neurology. 1964;14:616–622. doi: 10.1212/wnl.14.7.616. [DOI] [PubMed] [Google Scholar]
  • 11.Werdelin O., McCluskey R.T. The nature and the specificity of mononuclear cells in experimental autoimmune inflammations leading to their accumulation. J. Exp. Med. 1971;133:1242–1263. doi: 10.1084/jem.133.6.1242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Behan P.O., Kies M.W., Lisak R.P., Sheremata W., Lamarche J.B. Immunologic mechanisms in experimental encephalomylitis in non-human primates. Arch. Neurol. 1973;29:4–9. doi: 10.1001/archneur.1973.00490250022002. [DOI] [PubMed] [Google Scholar]
  • 13.Spitler L.E., von Muller C.M., Fudenberg H., Eylar E.H. Experimental allergic encephalitis, dissociation of cellular immunity to brain protein and disease production. J. Exp. Med. 1972;136:156–174. doi: 10.1084/jem.136.1.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Desjardins W.A., Shapira R., Fritz R.B. Isolation and characterization of rabbit antibodies to bovine myelin basic protein. Immunochemistry. 1978;15:47–54. doi: 10.1016/0161-5890(78)90025-1. [DOI] [PubMed] [Google Scholar]
  • 15.Raine C.S., Traugott U., Iqbal K., Snyder D.S., Cohen S.R., Farooq M., Norton W.T. Encephalitogenic properties of purified preparations of bovine oligodendrocytes tested in guinea pigs. Brain Res. 1978;142:85–96. doi: 10.1016/0006-8993(78)90178-6. [DOI] [PubMed] [Google Scholar]
  • 16.Lebar R., Voisin G.A. Studies on autoimmune encephalomyelitis in the guinea pig. Int. Arch. Allergy. 1974;46:82–103. doi: 10.1159/000231115. [DOI] [PubMed] [Google Scholar]
  • 17.Oldstone M.B.A., Dixon F.J. Immunohistochemical study of allergic encephalomyelitis. Am. J. Pathol. 1968;52:251–257. [PMC free article] [PubMed] [Google Scholar]
  • 18.Bornstein M.B., Appel S.H. The application of tissue culture to the study of experimental allergic encephalomyelitis, I. Patterns of demyelination. J. Neurophathol. Exp. Pathol. 1961;20:141–157. [Google Scholar]
  • 19.Fry J.M., Wissbarth S., Lehrer G.M., Bornstein M.B. Cerebroside antibody inhibits sulphatide synthesis and myelination and demyelination in cord tissue cultures. Science. 1974;183:540–542. doi: 10.1126/science.183.4124.540. [DOI] [PubMed] [Google Scholar]
  • 20.Lebar R., Boutry J.M., Vincent C., Robineaux R., Voisin G.A. Studies of autoimmune encephalomyelitis in the guinea pig: II. An in vitro investigation on the nature, properties and specificity of the serum demyelinating factor. J. Immunol. 1976;116:1439–1446. [PubMed] [Google Scholar]
  • 21.Traugott U., Raine C.S. Experimental allergic encephalomyelitis in inbred guinea pigs: correlation of decrease in early T cells with clinical signs in suppressed and unsuppressed animals. Cell. Immunol. 1977;34:146–155. doi: 10.1016/0008-8749(77)90237-4. [DOI] [PubMed] [Google Scholar]
  • 22.Traugott U., Stone S.H., Raine C.S. Experimental allergic encephalomyelitis: migration of early T cells from the circulation into the central nervous system. J. Neurol. Sci. 1978;36:55–61. doi: 10.1016/0022-510x(78)90161-2. [DOI] [PubMed] [Google Scholar]
  • 23.Stoner G.L., Brosnan C.F., Wisniewski H.M., Bloom B.R. Studies on demyelination by activated lymphocytes in the rabbit eye. I. Effects of a mononuclear cell infiltrate induced by products of activated lymphocytes. J. Immunol. 1977;118:2094–2102. [PubMed] [Google Scholar]
  • 24.Brosnan C.F., Stoner G.L., Bloom B.R., Wisniewski H.M. Studies on demyelination by activated lymphocytes in the rabbit eye. II. Antibody-dependent cell-mediated demyelination. J. Immunol. 1977;118:2103–2110. [PubMed] [Google Scholar]
  • 25.Amtorp O., Sørensen S.C. The concentration of γ-globulin in cerebrospinal fluid in rabbits with experimental allergic encephalomyelitis. Acta Neurol. Scand. 1973;49:323–326. [PubMed] [Google Scholar]
  • 26.Amtorp O., Sørensen S.C. The permeability of the blood-brain barrier to 51Cr-EDTA in rabbits with experimental allergic encephalomyelitis. Acta Neurol. Scand. 1973;49:327–330. doi: 10.1111/j.1600-0404.1973.tb01305.x. [DOI] [PubMed] [Google Scholar]
  • 27.Tourtellotte W.W., Parker J.A. Multiple sclerosis: correlation between immunoglobulin-G in cerebrospinal fluid and brain. Science. 1966;154:1044–1046. doi: 10.1126/science.154.3752.1044. [DOI] [PubMed] [Google Scholar]
  • 28.Gustein H.S., Cohen S.R. Spinal fluid differences in experimental allergic encephalomyelitis and multiple sclerosis. Science. 1978;199:301–303. doi: 10.1126/science.619457. [DOI] [PubMed] [Google Scholar]
  • 29.Lampert P. Electron microscopic studies on ordinary and hyperacute experimental allergic encephalomyelitis. Acta Neuropathol. 1967;9:99–126. doi: 10.1007/BF00691436. [DOI] [PubMed] [Google Scholar]
  • 30.Yonezawa T., Saida T., Hasegawa M. Demyelinating pattern with experimental allergic encephalomyelitis and anti-sera studied in vitro: time lapse cinematographic analysis. Neurology. 1976;26 doi: 10.1212/wnl.26.6_part_2.42. Abstract 42. [DOI] [PubMed] [Google Scholar]
  • 31.Benetato G., Gabrielescu E., Boros I. Histochemistry of cerebral proteases in experimental allergic encephalomyelitis. Rev. Roum. Physiol. 1965;2:379–384. [Google Scholar]
  • 32.Smith M.E., Rauch H.R. Metabolic activity of central nervous system in rats and monkeys with experimental allergic encephalomyelitis. J. Neurochem. 1974;23:775–783. doi: 10.1111/j.1471-4159.1974.tb04403.x. [DOI] [PubMed] [Google Scholar]
  • 33.Cuzner M.L., Davison A.N. Changes in cerebral lysosomal enzyme activity and lipids in multiple sclerosis. J. Neurol. Sci. 1973;19:29–36. doi: 10.1016/0022-510x(73)90053-1. [DOI] [PubMed] [Google Scholar]
  • 34.Smith M.E. The role of proteolytic enzymes in demyelination in experimental allergic encephalomyelitis. Neurochem. Res. 1977;2:233–246. doi: 10.1007/BF00969354. [DOI] [PubMed] [Google Scholar]
  • 35.Davison A.N., Cuzner M.L. Immunochemistry and biochemistry of myelin. Brit. Med. Bull. 1977;33:60–66. doi: 10.1093/oxfordjournals.bmb.a071398. [DOI] [PubMed] [Google Scholar]
  • 36.Buletza G.F., Smith M.E. Enzymic hydrolysis of myelin basic protein and other proteins in central nervous system and lymphoid tissues from normal and demyelinating rats. Biochem. J. 1976;156:627–633. doi: 10.1042/bj1560627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Woelk H., Kanig K., Peiler-Ichikawa K. Phospholipid metabolism in experimental allergic encephalomyelitis: activity of mitochondrial phospholipase A2 of rat brain towards specifically labelled 1,2-diacyl-1-alk-1′-, enyl-2-acyl- and 1-alkyl-2-acyl-SN-glycero-3-phosphorylcholine. J. Neurochem. 1974;23:739–743. doi: 10.1111/j.1471-4159.1974.tb04399.x. [DOI] [PubMed] [Google Scholar]
  • 38.Woelk H., Kanig K. Phospholipid metabolism in experimental allergic encephalomyelitis: activity of brain phospholipase A1 towards specifically labelled glycerophospholipids. J. Neurochem. 1974;23:745–750. doi: 10.1111/j.1471-4159.1974.tb04398.x. [DOI] [PubMed] [Google Scholar]
  • 39.Vasan N.S., Bachhawat B.K. Enzymic studies on sulphatide metabolism in different stages of experimental allergic encephalomyelitis. J. Neurochem. 1971;18:1853–1859. doi: 10.1111/j.1471-4159.1971.tb09591.x. [DOI] [PubMed] [Google Scholar]
  • 40.Maggio B., Maccinoni H.J., Cumar F.A. Arylsulphatase A (EC 3.1.6.1) activity in rat central nervous system during experimental allergic encephalomyelitis. J. Neurochem. 1973;20:503–510. doi: 10.1111/j.1471-4159.1973.tb12149.x. [DOI] [PubMed] [Google Scholar]
  • 41.Paterson P.Y. Autoimmune Neurological disease: experimental animal systems and implications for multiple sclerosis. In: Talal N., editor. Autoimmunity. Academic Press; NY: 1977. pp. 643–692. [Google Scholar]
  • 42.Raine C.S. Experimental allergic encephalomyelitis and related conditions. In: Zimmerman H.M., editor. Vol. 3. Grune & Stratton; N.Y: 1976. pp. 225–251. (Progress in Neuropathology). [Google Scholar]
  • 43.Raine C.S., Traugott U., Stone S.H. Suppression of chronic allergic encephalomyelitis: relevance to multiple sclerosis. Science. 1978;201:445–447. doi: 10.1126/science.78524. [DOI] [PubMed] [Google Scholar]
  • 44.Raine C.S., Traugott U., Stone S.H. Chronic relapsing experimental allergic encephalomyelitis: CNS plaque development in unsuppressed and suppressed animals. Acta Neuropath. 1978;43:43–53. doi: 10.1007/BF00684997. [DOI] [PubMed] [Google Scholar]
  • 1.Adams C.W.M. Pathology of multiple sclerosis: progression of the lesion. Brit. Med. Bull. 1977;33:15–20. doi: 10.1093/oxfordjournals.bmb.a071388. [DOI] [PubMed] [Google Scholar]
  • 2.Fog T. Vessel-plaque relations, and cerebrospinal fluid and brain tissue changes in multiple sclerosis. Acta Neurol. Scand. 1964;(Suppl. 10):9–15. [PubMed] [Google Scholar]
  • 3.Lumsden C.E. The neuropathology of multiple sclerosis. In: Vinken P.J., Bruyn G.W., editors. Multiple Sclerosis and Other Demyelinating Diseases. Vol. 9. North-Holland; Amsterdam: 1970. pp. 217–309. (Handbook of Clinical Neurology). [Google Scholar]
  • 4.Guseo A., Jellinger K. The significance of perivascular infiltrations in multiple sclerosis. J. Neurol. 1975;211:51–60. doi: 10.1007/BF00312463. [DOI] [PubMed] [Google Scholar]
  • 5.Jellinger K. Inflammatory lesions in multiple sclerosis. In: Delmotte P., Hommes O.R., Gonsette R., editors. Immunosuppressive Therapy in Multiple Sclerosis. European Press; Gent: 1977. pp. 164–180. Chapter XI. [Google Scholar]
  • 6.Prineas J.W., Wright R.G. Macrophages, lymphocytes and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab. Invest. 1978;38:409–421. [PubMed] [Google Scholar]
  • 7.Ibrahim M.Z.M., Adams C.W.M. The relationship between enzyme activity and neuroglia in early plaques of multiple sclerosis. J. Pathol. Bacteriol. 1965;90:239–243. doi: 10.1002/path.1700900126. [DOI] [PubMed] [Google Scholar]
  • 8.Raine C.S., Hummelgard A., Swanson E., Bornstein M.B. Multiple sclerosis: serum-induced demyelination in vitro. J. Neurol. Sci. 1973;20:127–148. doi: 10.1016/0022-510x(73)90026-9. [DOI] [PubMed] [Google Scholar]
  • 9.Prineas J. Pathology of the early lesion in multiple sclerosis. Human Pathology. 1975;6:531–554. doi: 10.1016/s0046-8177(75)80040-2. [DOI] [PubMed] [Google Scholar]
  • 10.Esiri M.M. Immunoglobulin-containing cells in mutliple sclerosis plaques. Lancet. 1977;I:478–480. doi: 10.1016/s0140-6736(77)91603-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Adams C.W.M. The onset and progression of the lesion in multiple sclerosis. J. Neurol. Sci. 1975;25:165–182. doi: 10.1016/0022-510x(75)90138-0. [DOI] [PubMed] [Google Scholar]
  • 12.Suzuki K., Andrews J.M., Waltz J.M., Terry R.D. Ultrastructural studies of multiple sclerosis. Lab. Invest. 1969;20:444–454. [PubMed] [Google Scholar]
  • 13.Gonatas N.K. Ultrastructural observation in a case of multiple sclerosis. J. Neuropath. Exp. Neurol. 1970;29:149. [Google Scholar]
  • 14.Arstila A.U., Riekkinen P., Rinne U.K., Laitinen L. Studies on the pathogenesis of multiple sclerosis. Eur. Neurol. 1973;9:1–20. doi: 10.1159/000114197. [DOI] [PubMed] [Google Scholar]
  • 15.Dubois-Dalcq M., Schumacher G., Worthington E.K. Immunoperoxidase studies on multiple sclerosis brain. Neurology. 1975;25:496. [PubMed] [Google Scholar]
  • 16.Haire M. Significance of virus antibodies. Brit. Med. Bull. 1977;33:40–44. doi: 10.1093/oxfordjournals.bmb.a071394. [DOI] [PubMed] [Google Scholar]
  • 17.Ter Meulen V., Koprowski H., Iwasaki Y., Käckell Y.M., Müller D. Fusion of cultured MS brain cells with indicator cells: presence of nucleocapsids and virions and isolation of parainfluenza type virus. Lancet. 1972;II:1–5. doi: 10.1016/s0140-6736(72)91273-1. [DOI] [PubMed] [Google Scholar]
  • 18.Tanaka R., Iwasaki Y., Koprowski H. Intracisternal virus-like particles in brain of a multiple sclerosis patient. J. Neurol. Sci. 1976;28:121–126. doi: 10.1016/0022-510X(76)90053-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Tanaka R., Santoli D., Koprowski H. Unusual intranuclear filaments in the circulating lymphocytes of patients with MS and optic neuritis. Am. J. Pathol. 1976;83:245–254. [PMC free article] [PubMed] [Google Scholar]
  • 20.Raine C.S., Prineas J.W., Sheppard R.D., Bornstein M.B., Dubois-Dalcq M. Immunocytochemical studies for the localization of measles antigen in MS plaques and measles virus-infected CNS tissue. J. Neurol. Sci. 1977;33:12–20. doi: 10.1016/0022-510x(77)90177-0. [DOI] [PubMed] [Google Scholar]
  • 21.Raine C.S., Schaumburg H.H., Snyder D.H., Suzuki K. Intranuclear “paramyxovirus-like” material in multiple sclerosis, adreno-leukodystrophy and Kuf's disease. J. Neurol. Sci. 1975;25:29–41. doi: 10.1016/0022-510x(75)90184-7. [DOI] [PubMed] [Google Scholar]
  • 22.Carp R.I., Licursi P.C., Merz P.A., Merz G.S. Decreased percentage of polymorphonuclear neutrophils in mouse peripheral blood after inoculation with material from multiple sclerosis patients. J. Exp. Med. 1972;136:618–629. doi: 10.1084/jem.136.3.618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Koldovsky U., Koldovsky P., Henle G., Henle W., Ackermann R., Haase G. MS-associated agent: transmission to animals and some properties of the agent. Infect. Immun. 1975;12:1355–1366. doi: 10.1128/iai.12.6.1355-1366.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Licursi P.C., Merz P.A., Merz G.S., Carp R.I. Scrapie-induced changes in the percentage of polymorphonuclear neutrophils in mouse peripheral blood. Infect. Immun. 1972;6:370–376. doi: 10.1128/iai.6.3.370-376.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Madden D.L., Krezlewicz A., Gravell M., Sever J.L., Tourtellotte W.W. Multiple sclerosis-associated agent (MSAA): failure to confirm an association with multiple sclerosis. Neurology. 1978;28:295–299. doi: 10.1212/wnl.28.3.295. [DOI] [PubMed] [Google Scholar]
  • 26.Cook S.D., Natelson B.H., Levin B.E., Chavis P.S., Dowling P.C. Further evidence of a possible association between house dogs and multiple sclerosis. Ann. Neurol. 1978;3:141–143. doi: 10.1002/ana.410030209. [DOI] [PubMed] [Google Scholar]
  • 27.Cook S.D., Dowling P.C., Russell W.C. Multiple sclerosis and canine distemper. Lancet. 1978;I:605–606. doi: 10.1016/s0140-6736(78)91047-4. [DOI] [PubMed] [Google Scholar]
  • 28.Mitchell D.N., Porterfield J.S., Micheletti R., Lange L.S., Goswami K.K.A., Taylor P., Jacobs J.P., Hockley D.J., Salsbury A.J. Isolation of an infectious agent from bone-marrows of patients with multiple sclerosis. Lancet. 1978;II:387–391. doi: 10.1016/s0140-6736(78)91862-7. [DOI] [PubMed] [Google Scholar]
  • 1.Yanigihara T., Cumings J.N. Alterations of phospholipids particularly plasmalogens, in the demyelination of multiple sclerosis as compared with that of cerebral oedema. Brain. 1969;92:59–70. doi: 10.1093/brain/92.1.59. [DOI] [PubMed] [Google Scholar]
  • 2.Einstein E.R., Dalal K.B., Csejtey J. Increased protease activity and changes in basic proteins and lipids in multiple sclerosis plaques. J. Neurol. Sci. 1970;11:109–121. doi: 10.1016/0022-510x(70)90121-8. [DOI] [PubMed] [Google Scholar]
  • 3.Cuzner M.L., Davison A.N. Changes in cerebral lysosomal enzyme activity and lipids in multiple sclerosis. J. Neurol. Sci. 1973;19:29–36. doi: 10.1016/0022-510x(73)90053-1. [DOI] [PubMed] [Google Scholar]
  • 4.Einstein E.R., Csejtey J., Dalal K.B., Adams C.W.M., Bayliss O.B., Hallpike J.F. Proteolytic activity and basic protein loss in and around multiple sclerosis plaques: combined biochemical and histochemical observations. J. Neurochem. 1972;19:653–662. doi: 10.1111/j.1471-4159.1972.tb01382.x. [DOI] [PubMed] [Google Scholar]
  • 5.Yu R.K., Ledeen R.W., Eng L.F. Ganglioside abnormalities in multiple sclerosis. J. Neurochem. 1974;23:169–174. doi: 10.1111/j.1471-4159.1974.tb06931.x. [DOI] [PubMed] [Google Scholar]
  • 6.J. Newcombe and spM.L. Cuzner, unpublished observations.
  • 7.Eng L.F., Vanderhaeghen J.J., Bignami A., Gerstl B. An acidic protein isolated from fibrous astrocytes. Brain Res. 1971;28:351–354. doi: 10.1016/0006-8993(71)90668-8. [DOI] [PubMed] [Google Scholar]
  • 8.Tourtellotte W.W., Parker J.A. Multiple sclerosis: brain immunoglobulin G and albumin. Science. 1967;214:683–686. doi: 10.1038/214683a0. [DOI] [PubMed] [Google Scholar]
  • 9.Clausen J., Hansen I.B. Myelin constituents of human central nervous system. Acta Neurol. Scand. 1970;41:1–17. doi: 10.1111/j.1600-0404.1970.tb05601.x. [DOI] [PubMed] [Google Scholar]
  • 10.Woelk H., Borri P. Lipid and fatty acid composition of myelin purified from normal and multiple sclerosis brains. Eur. Neurol. 1973;10:250–260. doi: 10.1159/000114281. [DOI] [PubMed] [Google Scholar]
  • 11.Alling C., Vanier M.T., Svennerholm L. Lipid alterations in apparently normal white matter in multiple sclerosis. Brain Res. 1971;35:325–336. doi: 10.1016/0006-8993(71)90478-1. [DOI] [PubMed] [Google Scholar]
  • 12.Cumings J.N., Goodwin H. Sphingolipids and phospholipids of myelin in multiple sclerosis. Lancet. 1968;ii:664–665. doi: 10.1016/s0140-6736(68)92510-5. [DOI] [PubMed] [Google Scholar]
  • 13.Gerstl B., Eng L.F., Tavaststjerna M.G., Smith J.K., Kruse S.L. Lipids and proteins in multiple sclerosis white matter. J. Neurol. 1970;17:677–698. doi: 10.1111/j.1471-4159.1970.tb00547.x. [DOI] [PubMed] [Google Scholar]
  • 14.Suzuki K., Kamoshita S., Eto Y., Tourtellotte W., Gonatas J.O. Myelin in multiple sclerosis. Arch. Neurol. 1973;28:293–297. doi: 10.1001/archneur.1973.00490230029002. [DOI] [PubMed] [Google Scholar]
  • 15.Wolfgram F. Chemical theories of the demyelination in multiple sclerosis. In: Wolfgram F., Ellison G.W., Stevens J.G., Andrews J.M., editors. Multiple Sclerosis — Immunology, Virology and Ultrastructure. Academic Press; N.Y. and London: 1972. pp. 173–181. [Google Scholar]
  • 16.Cuzner M.L., Barnard R.O., MacGregor B.J.L., Borshell N.J., Davison A.N. Myelin composition in acute and chronic multiple sclerosis in relation to cerebral lysosomal activity. J. Neurol. Sci. 1976;29:323–334. doi: 10.1016/0022-510x(76)90181-7. [DOI] [PubMed] [Google Scholar]
  • 17.Baker R.W.R., Thompson R.H.S., Zilkha K.J. Fatty acid composition of brain lecithins in multiple sclerosis. Lancet. 1963;I:26–27. doi: 10.1016/s0140-6736(63)91152-8. [DOI] [PubMed] [Google Scholar]
  • 18.Thompson R.H.S. Fatty acid metabolism in multiple sclerosis. In: Ganguly J., Smellie R.M.S., editors. Current Trends in the Biochemistry of Lipids. Academic Press; London: 1972. pp. 103–111. [Google Scholar]
  • 19.Thompson R.H.S. Unsaturated fatty acids in multiple sclerosis. In: Davison A.N., Humphrey J.H., Liversedge A.L., McDonald W.L., Porterfield J.S., editors. Multiple Sclerosis Research. HMSO; London: 1975. pp. 184–191. [Google Scholar]
  • 20.Baker R.W.R., Sanders H., Thompson R.H.S., Zilkha K.J. Serum cholesterol linoleate levels in multiple sclerosis. J. Neurol. Neurosurg & Psychiat. 1965;28:212–217. doi: 10.1136/jnnp.28.3.212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Love W.C., Reynolds M., Coshel A., Callaghan N. Fatty acid patterns of serum lipids in multiple sclerosis and other diseases. Biochem. Soc. Trans. 1973;1:141–143. [Google Scholar]
  • 22.Millar J.H.D., Zilkha K.J., Langman M.J.S., Wright H.P., Smith A.D., Belin J., Thompson R.H.S. Double-blind trial of linoleate supplementation of the diet in multiple sclerosis. Brit. Med. J. 1973;1:765–768. doi: 10.1136/bmj.1.5856.765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Clausen J., Møller J. Allergic encephalomyelitis induced by brain antigen after deficiency in PUFA during myelination. In: Burdzy K., Kallós P., editors. Pathogenesis and Etiology of Demyelinating Diseases. Karger; Basel: 1969. pp. 224–233. (Suppl. to Int. Arch. Allergy, vol. 36) [Google Scholar]
  • 24.Meade C.J., Mertin J., Sheena J., Hunt R. Reduction by linoleic acid of the severity of experimental allergic encephalomyelitis in the guinea pig. J. Neurol. Sci. 1978;35:291–308. doi: 10.1016/0022-510x(78)90010-2. [DOI] [PubMed] [Google Scholar]
  • 25.Hirsch H.E., Duquette P., Parks M.E. The quantitative histochemistry of multiple sclerosis plaques: acid proteinase and other acid hydrolases. J. Neurochem. 1976;26:505–512. doi: 10.1111/j.1471-4159.1976.tb01503.x. [DOI] [PubMed] [Google Scholar]
  • 26.Arstila A.U., Riekkinen P., Rinne U.K., Laitinen L. Studies on the pathogenesis of multiple sclerosis: participation of lysosomes in demyelination in the central nervous system white matter outside plaques. Eur. Neurol. 1973;9:1–20. doi: 10.1159/000114197. [DOI] [PubMed] [Google Scholar]
  • 27.Ansell G.B., Spanner S. Plasmalogenase activity in normal and demyelinating tissue of the central nervous system. Biochem. J. 1968;108:207–209. doi: 10.1042/bj1080207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Bowen D.M., Davison A.N. Macrophages and cathepsin A activity in multiple sclerosis brain. J. Neurol. Sci. 1974;21:227–231. doi: 10.1016/0022-510x(74)90074-4. [DOI] [PubMed] [Google Scholar]
  • 29.Hirsch H.E., Parks M.E. Acid proteinases and other acid hydrolases in experimental allergic encephalomyelitis: pinpointing the source. J. Neurochem. 1975;24:853–858. doi: 10.1111/j.1471-4159.1975.tb03647.x. [DOI] [PubMed] [Google Scholar]
  • 30.Woelk H., Peiler-Ichikawa K. On the activity of phospholipase A2, compared with 1-Alk-1′-enyl-2-acyl- and 1-Alkyl-2-acyl- glycerophosphatides in multiple sclerosis. J. Neurol. 1974;207:319–326. doi: 10.1007/BF00312585. [DOI] [PubMed] [Google Scholar]
  • 1.Halliday A.M., McDonald W.I. Pathophysiology of demyelinating disease. Brit. Med. Bull. 1977;33:21–27. doi: 10.1093/oxfordjournals.bmb.a071390. [DOI] [PubMed] [Google Scholar]
  • 2.Robinson K., Rudge P. Abnormalities of the auditory evoked potentials in patients with multiple sclerosis. Brain. 1977;100:19–40. doi: 10.1093/brain/100.1.19. [DOI] [PubMed] [Google Scholar]
  • 3.Bornstein M.B., Crain S.M. Functional studies of cultured brain tissues as related to ‘demyelinative’ disorders. Science. 1965;148:1242–1244. doi: 10.1126/science.148.3674.1242. [DOI] [PubMed] [Google Scholar]
  • 4.Seil F.J. Tissue culture studies of demyelinating disease: a critical review. Ann. Neurol. 1977;2:345–355. doi: 10.1002/ana.410020417. [DOI] [PubMed] [Google Scholar]
  • 5.Schauf C.L., Schauf V., Davis F.A., Mizen M.B. Complement-dependent serum: neuroelectric blocking activity in multiple sclerosis. Neurology. 1978;28:426–430. doi: 10.1212/wnl.28.5.426. [DOI] [PubMed] [Google Scholar]
  • 6.Prineas J. Red blood cell size in multiple sclerosis. Acta Neurol. Scand. 1968;44:81–90. doi: 10.1111/j.1600-0404.1968.tb07445.x. [DOI] [PubMed] [Google Scholar]
  • 7.Thompson R.H.S. Unsaturated fatty acids in multiple sclerosis. In: Davison A.N., Humphrey J.H., Liversedge A.L., McDonald W.I., Porterfield J.S., editors. Multiple Sclerosis Research. HMSO; London: 1975. pp. 184–197. [Google Scholar]
  • 8.Love W.C., Reynolds M., Cashel A., Callaghan N. Fatty acid patterns of serum lipids in multiple sclerosis and other diseases. Biochem. Soc. Trans. 1973;1:141–143. doi: 10.1136/bmj.3.5922.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Källen B., Nilsson O., Thelin C. Effect of encephalitogenic protein on migration in agarose of leukocytes from patients with multiple sclerosis. Acta Neurol. Scand. 1976;55:47–56. [PubMed] [Google Scholar]
  • 10.Levy N.L., Auerbach P.S., Hayes E.C. A blood test for multiple sclerosis based on the adherence of lymphocytes to measles-infected cells. New Engl. J. Med. 1976;294:1423–1427. doi: 10.1056/NEJM197606242942604. [DOI] [PubMed] [Google Scholar]
  • 11.Nordal H.J., Frøland S.S. Lymphocyte populations and cellular immune reactions in vitro in patients with multiple sclerosis. Clin. Immunol. Immunopath. 1978;9:87–96. doi: 10.1016/0090-1229(78)90125-3. [DOI] [PubMed] [Google Scholar]
  • 12.Field E.J., Caspary E.A. Lymphocyte sensitization: an in vitro test for cancer. Cancet. 1970;ii:1337–1341. doi: 10.1016/s0140-6736(70)92361-5. [DOI] [PubMed] [Google Scholar]
  • 13.Field E.J., Shenton B.K., Joyce C. Specific laboratory test for diagnosis of multiple sclerosis. Brit. Med. J. 1974;1:412–414. doi: 10.1136/bmj.1.5905.412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Meyer-Rienecker H., Jenssen H.L., Köhler H., Gunther J.K. Makrophagen-Elektrophorese-Mobilitäts-LAD-test als diagnostisches Verfahren für die multiple sklerose. J. Neurol. 1976;211:229–240. doi: 10.1007/BF00313233. [DOI] [PubMed] [Google Scholar]
  • 15.Lewkonia R.M., Kerr E.J.L., Irvine W.J. Clinical evaluation of the macrophage electrophoretic mobility test for cancer. Brit. J. Cancer. 1974;30:532–537. doi: 10.1038/bjc.1974.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Crozier E.H., Hollinger M.E., Woodend B.E., Robertson J.H. An assessment of the macrophage electrophoretic mobility test in cancer diagnosis. J. Clin. Path. 1976;29:608–609. doi: 10.1136/jcp.29.7.608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Mertin J., Hughes P., Caspary E.A., Thomson A.M., Foster J.B., Stewart-Wynne E.G. Non-specificity of laboratory test for diagnosis of multiple sclerosis. Brit. Med. J. 1974;4:567–569. doi: 10.1136/bmj.4.5944.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Field E.J., Joyce G., Smith B.M. Erythrocyte-UFA (EUFA) mobility test for multiple sclerosis: implications for pathogenesis and handling of the disease. J. Neurol. 1977;214:113–127. doi: 10.1007/BF02430349. [DOI] [PubMed] [Google Scholar]
  • 19.Stoof J.C., Vrijmoed-de Vries M.C., Koetsier J.C., Langevoort H.L. Evaluation of the red blood cell cytopherometric test for the diagnosis of multiple sclerosis. Acta Neurol. Scand. 1977;56:170–176. doi: 10.1111/j.1600-0404.1977.tb01421.x. [DOI] [PubMed] [Google Scholar]
  • 20.Forrester J.A., Smith W.J. Screening of children at risk of multiple sclerosis. Lancet. 1977;ii:453–454. doi: 10.1016/s0140-6736(77)90631-6. [DOI] [PubMed] [Google Scholar]
  • 21.Tourtellotte W.W. What is multiple sclerosis? Laboratory criteria for diagnosis. In: Davison A.N., Humphrey J.H., Liversedge A.L., McDonald W.I., Porterfield J.S., editors. Multiple Sclerosis Research. HMSO; London: 1975. pp. 9–26. [Google Scholar]
  • 22.Olsson J.E., Pettersson B. A comparison between agar gel electrophoresis and CSF serum quotients of IgG and albumin in neurological diseases. Acta Neurol. Scand. 1976;53:308–322. doi: 10.1111/j.1600-0404.1976.tb04350.x. [DOI] [PubMed] [Google Scholar]
  • 23.Frick E., Schied-Seydel L. Untersuchungen mit I131-markiertem γ-globulin zur frage der abstammung der liguoreiweisskörper. Klin. Wschr. 1958;36:857–863. doi: 10.1007/BF01485232. [DOI] [PubMed] [Google Scholar]
  • 24.Cohen S., Bannister R. Immunoglobulin synthesis within the central nervous system in disseminated sclerosis. Lancet. 1967;I:366–367. doi: 10.1016/s0140-6736(67)92900-5. [DOI] [PubMed] [Google Scholar]
  • 25.Sandberg-Wollheim M., Zettervall O., Mueller R. In vitro synthesis of IgG by cells from the cerebrospinal fluid in a patient with multiple sclerosis. Clin. Exp. Immunol. 1969;4:401. [PMC free article] [PubMed] [Google Scholar]
  • 26.Sandberg-Wollheim M. Immunoglobulin synthesis in vitro by cerebrospinal fluid cells in patients with multiple sclerosis. Scand. J. Immunol. 1974;3:717–730. doi: 10.1111/j.1365-3083.1974.tb01307.x. [DOI] [PubMed] [Google Scholar]
  • 27.Lowenthal A. Elsevier; Amsterdam: 1964. Agar Gel Electrophoresis in Neurology. [Google Scholar]
  • 28.Laterre E.C. Arsica; Bruxelles: 1965. Les proteines du liquide céphalo-rachidien a l'état normal et pathologique. Maloine, Paris. [Google Scholar]
  • 29.Link H. Comparison of electrophoresis on agar gel and agarose gel in the evaluation of gamma-globulin abnormalities in cerebrospinal fluid and serum in multiple sclerosis. Clin. Chim. Acta. 1973;46:383–389. doi: 10.1016/0009-8981(73)90251-9. [DOI] [PubMed] [Google Scholar]
  • 30.Thompson E.J. Laboratory diagnosis of multiple sclerosis: immunological and biochemical aspects. Brit. Med. Bull. 1977;33:28–33. doi: 10.1093/oxfordjournals.bmb.a071391. [DOI] [PubMed] [Google Scholar]
  • 31.Johnson K.P., Nelson B.J. Multiple sclerosis: diagnostic usefulness of cerebrospinal fluid. Ann. Neurol. 1977;2:425. doi: 10.1002/ana.410020515. [DOI] [PubMed] [Google Scholar]
  • 32.Laterre E.C., Callewaert A., Heremans J.F., Sfaello Z. Electrophoretic morphology of gamma globulins in cerebrospinal fluid of multiple sclerosis and other diseases of the nervous system. Neurology. 1970;20:982–990. doi: 10.1212/wnl.20.10.982. [DOI] [PubMed] [Google Scholar]
  • 33.Link H., Zettervall O. Multiple sclerosis: disturbed kappa: lambda chain ratio of immunoglobulin G in cerebrospinal fluid. Clin. Exp. Immunol. 1970;6:435–438. [PMC free article] [PubMed] [Google Scholar]
  • 34.Vandvik B. Oligoclonal IgG and free light chains in the cerebrospinal fluid of patients with multiple sclerosis and infectious diseases of the central nervous system. Scand. J. Immunol. 1977;6:913–922. doi: 10.1111/j.1365-3083.1977.tb00412.x. [DOI] [PubMed] [Google Scholar]
  • 35.Vandvik B., Natvig J.B., Wiger D. IgG1 subclass restriction of oligoclonal IgG from cerebrospinal fluids and brain extracts in patients with multiple sclerosis and subacute encephalitides. Scand. J. Immunol. 1976;5:427–436. doi: 10.1111/j.1365-3083.1976.tb00297.x. [DOI] [PubMed] [Google Scholar]
  • 36.E.J. Thompson, P. Kaufmann, R.C. Shortman, P. Rudge and W.I. McDonald, Oligoclonal immunoglobulins and plasma cells in spinal fluid of patients with multiple sclerosis. In preparation. [DOI] [PMC free article] [PubMed]
  • 37.Vandvik B., Natvig J.B., Norrby E. IgG1 subclass restriction of oligoclonal measles virus-specific IgG antibodies in patients with subacute sclerosing panencephalitis and in a patient with multiple sclerosis. Scand. J. Immunol. 1977;6:651–657. doi: 10.1111/j.1365-3083.1977.tb02145.x. [DOI] [PubMed] [Google Scholar]
  • 38.Vandvik B., Norrby E., Nordal H.J., Degré M. Oligoclonal measles virus-specific IgG antibodies isolated by virus immunoabsorption of cerebrospinal fluids, brain extracts and sera of patients with subacute sclerosing pan-encephalitis and multiple sclerosis. Scand. J. Immunol. 1976;5:979–992. doi: 10.1111/j.1365-3083.1976.tb03050.x. [DOI] [PubMed] [Google Scholar]
  • 39.Fraser K.B. Multiple sclerosis: a virus disease? Brit. Med. Bull. 1977;33:34–39. doi: 10.1093/oxfordjournals.bmb.a071392. [DOI] [PubMed] [Google Scholar]
  • 40.Jefferis R., Drew R., Haire M. 1978. Immunoglobulin G subclasses in cerebrospinal fluid of patients with multiple sclerosis and in patients with neurological disease. In the press. [Google Scholar]
  • 41.Haire M. Significance of virus antibodies in multiple sclerosis. Brit. Med. Bull. 1977;33:40–44. doi: 10.1093/oxfordjournals.bmb.a071394. [DOI] [PubMed] [Google Scholar]
  • 42.Laurell A.B., Link H. Complement-fixing antibrain antibodies in multiple sclerosis. Acta Neurol. Scand. 1972;48:461–466. doi: 10.1111/j.1600-0404.1972.tb07567.x. [DOI] [PubMed] [Google Scholar]
  • 43.Ryberg B. Complement-fixing antibrain antibodies in multiple sclerosis. Acta Neurol. Scand. 1976;54:1–12. doi: 10.1111/j.1600-0404.1976.tb07616.x. [DOI] [PubMed] [Google Scholar]
  • 44.Sidén A. Crossed immunoelectrofocusing of cerebrospinal fluid immunoglobulins. J. Neurol. 1977;217:103–109. doi: 10.1007/BF00312923. [DOI] [PubMed] [Google Scholar]
  • 45.Whitaker J.N. Myelin encephalitogenic protein fragments in cerebrospinal fluid of persons with multiple sclerosis. Neurology. 1977;27:911–920. doi: 10.1212/wnl.27.10.911. [DOI] [PubMed] [Google Scholar]
  • 46.Naess A. Demonstration of T lymphocytes in cerebrospinal fluid. Scand. J. Immunol. 1976;5:165–168. doi: 10.1111/j.1365-3083.1976.tb03004.x. [DOI] [PubMed] [Google Scholar]
  • 47.Naess A., Nyland H. Multiple sclerosis: T lymphocytes in cerebrospinal fluid and blood. Eur. Neurol. 1978;17:61–66. doi: 10.1159/000114925. [DOI] [PubMed] [Google Scholar]
  • 48.Allen J.C., Sheremata W., Cosgrove J.B.R., Osterland K., Shea M. Cerebrospinal fluid T and B lymphocyte kinetics related to exacerbations of multiple sclerosis. Neurology. 1976;26:579–583. doi: 10.1212/wnl.26.6.579. [DOI] [PubMed] [Google Scholar]
  • 49.Lisak R.P., Levinson A.I., Zweiman B., Abdou N.I. T and B lymphocytes in multiple sclerosis. Clin. Exp. Immunol. 1975;22:30–34. [PMC free article] [PubMed] [Google Scholar]
  • 50.Arnason B.G.W., Oger J., Kester P. Increased B cells in multiple sclerosis and Schilder's disease. Neurology. 1974;24:385. [Google Scholar]
  • 1.Thompson E.J. Laboratory diagnosis of multiple sclerosis: immunological and biochemical aspects. Brit. Med. Bull. 1977;33:28–33. doi: 10.1093/oxfordjournals.bmb.a071391. [DOI] [PubMed] [Google Scholar]
  • 2.Haire M. Significance of virus antibodies in multiple sclerosis. Brit. Med. Bull. 1977;33:40–44. doi: 10.1093/oxfordjournals.bmb.a071394. [DOI] [PubMed] [Google Scholar]
  • 3.Abramsky O., Lisak R.P., Silberberg D.H., Pleasure D.D. Antibodies to oligodendroglia in patients with multiple sclerosis. New Engl. J. Med. 1977;298:1207–1211. doi: 10.1056/NEJM197712012972204. [DOI] [PubMed] [Google Scholar]
  • 4.Johnson K.P., Panitch H.S., Hafler D. Humoral Immunity in Neurological Diseases. Nato Avanced Study Institute; 1978. Antibodies to myelin basic protein in MS and SSPE. Abs. 35. [Google Scholar]
  • 5.Bornstein M.B., Appel S.H. The application of tissue culture to the study of experimental ‘allergic’ encephalomyelitis. I. Patterns of demyelination. J. Neuropathol. Exp. Neurol. 1961;20:141–157. [Google Scholar]
  • 6.Bornstein M.B., Hummelgard A. Multiple sclerosis: serum induced demyelination in tissue culture. In: Shuraki H., Yonezawa T., Kuroiwa Y., editors. The Aetiology and Pathogenesis of the Demyelinating Diseases. Japan Science Press; Tokyo: 1976. pp. 341–370. [Google Scholar]
  • 7.Field E.J., Hughes D. Toxicity of motor neurone disease serum for myelin in tissue culture. Brit. Med. J. 1965;2:1399–1401. doi: 10.1136/bmj.2.5475.1399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Dowling P.C., Kim S.U., Murray M.R. Serum 19S and 7S demyelinating antibodies in multiple sclerosis. J. Immunol. 1968;101:1101–1104. [PubMed] [Google Scholar]
  • 9.Bornstein M.B., Raine C.S. Multiple sclerosis and experimental allergic encephalomyelitis: specific demyelination of CNS in culture. Neuropathol. Appl. Neurobiol. 1977;3:359–367. [Google Scholar]
  • 10.Wolfgram F., Duquette P. Demyelinating antibodies in multiple sclerosis. Neurology. 1976;26:68–69. doi: 10.1212/wnl.26.6_part_2.68. [DOI] [PubMed] [Google Scholar]
  • 11.Sabri M.I., Davison A.N. Biosynthesis of myelin and neurotoxic factors in the serum of multiple sclerosis patients. In: Palo J., editor. Vol. 100. Plenum Press; 1978. pp. 19–25. (Myelination & Demyelination, Advances in Experimental Medicine and Biology). [DOI] [PubMed] [Google Scholar]
  • 12.Berg O., Kallén B. Studies of experimental allergic encephalomyelitis and multiple sclerosis with aid of glia cell culture. Acta Neurol. Scand. 1965;41(Suppl. 13):625–628. doi: 10.1111/j.1600-0404.1965.tb01938.x. [DOI] [PubMed] [Google Scholar]
  • 13.Koprowski H., Fernandes M.V. Autosensitization reactions in vitro. Contractual agglutination of sensitized lymph node cells in brain tissue culture accompanied by destruction of glial elements. J. Exp. Med. 1962;116:467–476. doi: 10.1084/jem.116.4.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Seil F.J. Tissue culture studies of demyelinating disease: a critical review. Ann. Neurol. 1977;2:345–355. doi: 10.1002/ana.410020417. [DOI] [PubMed] [Google Scholar]
  • 15.Raine C.S., Hummelgard A., Swanson E., Bornstein M.B. Multiple sclerosis: serum-induced demyelination in vitro: a light and electron microscopic study. J. Neurol. Sci. 1973;20:127–148. doi: 10.1016/0022-510x(73)90026-9. [DOI] [PubMed] [Google Scholar]
  • 16.Tachovsky T.G., Lisak R.P., Koprowski H., Theofilopoulos A.N., Dixon F.J. Immune complex in multiple sclerosis. Lancet. 1976;ii:997–999. doi: 10.1016/s0140-6736(76)90835-7. [DOI] [PubMed] [Google Scholar]
  • 17.Jacque C., Davous P., Baumann N. Circulating immune complexes and multiple sclerosis. Lancet. 1977;ii:408. doi: 10.1016/s0140-6736(77)90345-2. [DOI] [PubMed] [Google Scholar]
  • 18.Goust J.M., Chenais F., Carnes J.E., Hames C.G., Fudenburg H.H., Hogan E.L. Abnormal T cell subpopulations and circulating immune complexes in the Guillain-Barré syndrome and multiple sclerosis. Neurology. 1978;28:421–425. doi: 10.1212/wnl.28.5.421. [DOI] [PubMed] [Google Scholar]
  • 19.Cuzner M.L., Davison A.N., Rudge P. Proteolytic enzyme activity of blood leukocytes and CSF in MS. Ann. Neurol. 1978;4(4):337–344. doi: 10.1002/ana.410040409. [DOI] [PubMed] [Google Scholar]
  • 20.Nydegger U.E., Lambert P.H., Gerber H., Miescher P.A. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hapatitis B antigen. J. Clin. Invest. 1974;54:297–309. doi: 10.1172/JCI107765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Dubois-Dalcq M., Schumacher G., Worthington E.K. Immunoperoxidase studies on multiple sclerosis brain. Neurology. 1975;25:496. [PubMed] [Google Scholar]
  • 22.Woyciechowska J.L., Brzosko W.J. Immunofluorescence study of brain plaques from two patients with multiple sclerosis. Neurology. 1977;27:620–622. doi: 10.1212/wnl.27.7.620. [DOI] [PubMed] [Google Scholar]
  • 23.Movat H.Z. Vol. 35. 1976. Pathways to allergic inflammation. The sequelae of antigen-antibody complex formation; pp. 2434–2441. (Fed. Proc.). [PubMed] [Google Scholar]
  • 24.David J.R. Vol. 34. 1975. Macrophage activation by lymphocyte mediators; pp. 1730–1736. (Fed. Proc.). [PubMed] [Google Scholar]
  • 25.Tchorzewski H., Czernicki J., Maciejek Z. Polymorphonuclear leukocyte lysosome activities and lymphocyte transformation in multiple sclerosis and some other central nervous system chronic diseases. Eur. Neurol. 1976;14:386–396. doi: 10.1159/000114763. [DOI] [PubMed] [Google Scholar]
  • 26.Hansen N.E., Karle H., Jensen A., Bock E. Lysozyme activity in cerebrospinal fluid. Acta Neurol. Scand. 1977;55:418–424. doi: 10.1111/j.1600-0404.1977.tb05660.x. [DOI] [PubMed] [Google Scholar]
  • 27.Cohen S.R., Herndon R.M., McKhann G.M. Radioimmunoassay of myelin basic protein in spinal fluid: an index of active demyelination. New Engl. J. Med. 1976;295:1455–1457. doi: 10.1056/NEJM197612232952604. [DOI] [PubMed] [Google Scholar]
  • 28.Whitaker J.N. Myelin encephalitogenic protein fragments in cerebrospinal fluid of persons with multiple sclerosis. Neurology. 1977;27:911–920. doi: 10.1212/wnl.27.10.911. [DOI] [PubMed] [Google Scholar]
  • 29.Morley J. Prostaglandins and lymphokines in arthritis. Prostaglandins. 1974;8:315–326. doi: 10.1016/s0090-6980(74)80096-1. [DOI] [PubMed] [Google Scholar]
  • 30.Smith J.W., Steiner A.L., Parker C.W. Human lymphocyte metabolism. Effects of cyclic and non-cyclic nucleotides on stimulation by phytohaemogglutinin. J. Clin. Invest. 1971;50:442–448. doi: 10.1172/JCI106511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Morley J., Bray M.A., Gordon D. Bayer Symposium VI, Experimental Models of Chronic Inflammatory Diseases. Springer Verlag; 1977. The action of antiinflammatory drugs on the lymphocyte-macrophage axis; pp. 376–390. [Google Scholar]
  • 32.Offner H., Konat G., Clausen J. Effect of phytohaemagglutinin, basic protein and measles antigen on myo-(2-3H)inositol incorporation into phosphatidyl inositol of lymphocytes from patients with multiple sclerosis. Acta Neurol. Scand. 1974;50:791–800. doi: 10.1111/j.1600-0404.1974.tb02819.x. [DOI] [PubMed] [Google Scholar]
  • 33.Zabriskie J.B. Cell-mediated immunity to viral antigens in multiple sclerosis. In: Davison A.N., Humphrey J.H., Liversedge A.L., McDonald W.I., Porterfield J.S., editors. Multiple Sclerosis Research. HMSO; London: 1975. pp. 142–150. [Google Scholar]
  • 34.Sheremata W., Cosgrove J.B.R., Eylar E.H. Multiple sclerosis and cell-mediated hypersensitivity to myelin A1 protein. J. Neurol. Sci. 1976;27:413–425. doi: 10.1016/0022-510x(76)90212-4. [DOI] [PubMed] [Google Scholar]
  • 35.Colby-Germinario S.P., Sheremata W., Bain B., Eylar E.H. Studies of cellular sensitization to myelin antigens in multiple sclerosis — dissociation of MIF and LBT production in response to a peptide encephalitogenic in rhesus monkeys. J. Neurol. Sci. 1977;33:111–129. doi: 10.1016/0022-510x(77)90186-1. [DOI] [PubMed] [Google Scholar]
  • 36.Alvord E.C., Hsu P.C., Thon R. Leukocyte sensitivity to brain fractions in neurological diseases. Arch. Neurol. 1974;30:296–299. doi: 10.1001/archneur.1974.00490340024004. [DOI] [PubMed] [Google Scholar]
  • 37.Offner H., Rastogi S.C., Konat G., Clausen J. The enhancing effect of multiple sclerosis brain homogenates on the active E rosette forming lymphocytes. J. Neurol. 1978;218:245–252. doi: 10.1007/BF00312880. [DOI] [PubMed] [Google Scholar]
  • 38.Allen J.C., Sheremata W., Cosgrove J.B.R., Osterland K., Shea M. Cerebrospinal fluid T and B lymphocyte kinetics related to exacerbations of multiple sclerosis. Neurology. 1976;26:579–583. doi: 10.1212/wnl.26.6.579. [DOI] [PubMed] [Google Scholar]
  • 39.Sandberg-Wollheim M., Turesson I. Lymphocyte subpopulations in the cerebrospinal fluid and peripheral blood in patients with multiple sclerosis. J. Immunol. 1975;4:831–836. doi: 10.1111/j.1365-3083.1975.tb03724.x. [DOI] [PubMed] [Google Scholar]
  • 40.Lisak R.P., Levinson A.I., Zweiman B., Abdou N.I. T and B lymphocytes in multiple sclerosis. Clin. Exp. Immunol. 1975;22:30–34. [PMC free article] [PubMed] [Google Scholar]
  • 41.Arnason B.G.W., Oger J., Kester P. Increased B cells in multiple sclerosis and Schilder's disease. Neurology. 1974;24:385. [Google Scholar]
  • 42.Lisak R.P., Zweiman B. In vitro cell-mediated immunity of cerebrospinal fluid lymphocytes to myelin basic protein in primary demyelinating diseases. New Engl. J. Med. 1977;297:850–853. doi: 10.1056/NEJM197710202971602. [DOI] [PubMed] [Google Scholar]
  • 1.Levine S., Sowinski R. Suppression of the hyperacute form of experimental allergic encephalomyelitis by drugs. Arch. Int. Pharmacodyn. Ther. 1977;230:309–318. [PubMed] [Google Scholar]
  • 2.Arnason B.G.N. Immunosuppression in experimental demyelinating diseases. In: Wolfgram F., Ellison G.W., Stevens J.G., Andrews J.M., editors. Multiple Sclerosis - Immunology, Virology and Ultrastructure. Academic Press; New York: 1972. pp. 487–509. [Google Scholar]
  • 3.Brandriss M.W., Smith J.W., Friedman R.M. Suppression of experimental allergic encephalomyelitis by anti-metabolites. Ann. N.Y. Acad. Sci. 1965;122:356–368. doi: 10.1111/j.1749-6632.1965.tb20220.x. [DOI] [PubMed] [Google Scholar]
  • 4.Moyer A.W., Jervis G.A., Black J., Koprowski H., Cox H.R. Vol. 75. 1950. Action of adrenocorticotrophic hormone (ACTH) in experimental allergic encephalomyelitis of the guinea pig; p. 387. (Proc. Soc. Exp. Biol. Med.). [DOI] [PubMed] [Google Scholar]
  • 5.Kibler R.F. Large dose corticosteroid therapy of experimental and human demyelinating diseases. Ann. N.Y. Acad. Sci. 1965;122:469–478. doi: 10.1111/j.1749-6632.1965.tb20230.x. [DOI] [PubMed] [Google Scholar]
  • 6.Kabat E.A., Wolf A., Bezer A.E. Studies on acute disseminated encephalomyelitis produced experimentally in rhesus monkeys. VII. The effect of cortisone. J. Immunol. 1952;68:265. [PubMed] [Google Scholar]
  • 7.Alvord E.C., Shaw C.M., Hruby S., Kies M.W. Encephalitogen-induced inhibition of experimental allergic encephalomyelitis: prevention, suppression and therapy. Ann. N.Y. Acad. Sci. 1965;122:333–345. doi: 10.1111/j.1749-6632.1965.tb20218.x. [DOI] [PubMed] [Google Scholar]
  • 8.Einstein E.R., Csejtey J., Davis J.W., Rauch H.C. Protective action of the encephalitogen and other basic proteins in experimental allergic encephalomyelitis. Immunochemistry. 1968;5:567–575. doi: 10.1016/0019-2791(68)90092-x. [DOI] [PubMed] [Google Scholar]
  • 9.Levine S., Sowinski R., Kies M.W. Vol. 139. 1972. Treatment of experimental allergic encephalomyelitis; p. 506. (Proc. Soc. Exp. Biol. Med.). [DOI] [PubMed] [Google Scholar]
  • 10.Hashim G.A., Shilling F.J. Prevention of experimental allergic encephalomyelitis by non-encephalitogenic basic peptides. Arch. Biochem. Biophys. 1973;156:287–297. doi: 10.1016/0003-9861(73)90367-6. [DOI] [PubMed] [Google Scholar]
  • 11.Arnon R. Immunological approaches to control of multiple sclerosis desensitization studies. In: Davison A.N., Humphrey J.H., Liversedge A.L., McDonald W.I., Porterfield J.S., editors. Multiple Sclerosis Research. HMSO; London: 1975. pp. 271–283. [Google Scholar]
  • 12.Campbell B., Vogel P.J., Fisher E., Lorenz R. Myelin basic protein administration in multiple sclerosis. Arch. Neurol. 1973;29:10–15. doi: 10.1001/archneur.1973.00490250028003. [DOI] [PubMed] [Google Scholar]
  • 13.Clausen J., Møller J. Allergic encephalomyelitis induced by brain antigen after deficiency in polyunsaturated fatty acids during myelination. In: Burdzy K., Kallós P., editors. Pathogenesis and Etiology of Demyelinating Diseases. Vol. 36. Karger; Basel: 1969. pp. 224–233. (Suppl. to Int. Arch. Allergy Appl. Immunol.). [PubMed] [Google Scholar]
  • 14.Selivonchick D.P., Johnson P.V. Fat deficiency in rats during development of the central nervous system and susceptibility to experimental allergic encephalomyelitis. J. Nutr. 1975;105:288–300. doi: 10.1093/jn/105.3.288. [DOI] [PubMed] [Google Scholar]
  • 15.Meade C.J., Mertin J., Sheena J., Hunt R. Reduction by linoleic acid of the severity of experimental allergic encephalomyelitis in the guinea pig. J. Neurol. Sci. 1978;35:291–308. doi: 10.1016/0022-510x(78)90010-2. [DOI] [PubMed] [Google Scholar]
  • 16.Mertin J., Hunt R. Vol. 73. 1976. Influence of polyunsaturated fatty acids on survival of skin allografts and tumour incidence in mice; pp. 928–931. (Proc. Nat. Acad. Sci. (USA)). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Mertin J., Meade C.J., Hunt R., Sheena J. The importance of the spleen for the immunoinhibitory action of linoleic acid in mice. Int. Arch. Allergy Appl. Immunol. 1977;53:469–473. doi: 10.1159/000231785. [DOI] [PubMed] [Google Scholar]
  • 18.Mertin J., Hughes B., Shenton K., Dickerson J.P. In vitro inhibition by unsaturated fatty acids of the PPD- and PHA- induced lymphocyte response. Klin. Wschr. 1974;52:248–250. doi: 10.1007/BF01468599. [DOI] [PubMed] [Google Scholar]
  • 19.McIlhenny H.M., Levine S., Wiseman E.H., Sowinski R. Disposition and activity in experimental allergic encephalomyelitis of flumizole, a non-acidic, non-steroidal, anti-inflammatory agent. Exp. Neurol. 1978;58:126–137. doi: 10.1016/0014-4886(78)90128-0. [DOI] [PubMed] [Google Scholar]
  • 20.Mertin J., Stackpoole A. Suppression by essential fatty acids of experimental allergic encephalomyelitis is abolished by Indomethacin. Prostaglandins & Medicine. 1978 doi: 10.1016/0161-4630(78)90047-2. in press. [DOI] [PubMed] [Google Scholar]
  • 21.C. Bolton, M.L. Cuzner and A.N. Davison, unpublished observations.
  • 22.Morley J. Prostaglandins as regulators of lymphoid cell function in allergic inflammation: a basis for chronicity in rheumatoid arthritis. In: Dumonde D.C., editor. WHO/ARC Symposium on Infection and Immunology in the Rheumatic Diseases. Blackwells; London: 1976. [Google Scholar]
  • 23.Levine S., Sowinski R. Suppression of experimental allergic encephalomyelitis by 6-hydroxyphthalaldehydic acid, O-(p-chlorobenzyl) oxime (EN 3638) J. Immunol. 1978;120:602–606. [PubMed] [Google Scholar]
  • 24.Daniels J.C., Fajardo I., David J.R. Vol. 72. 1975. Two stages in lymphocyte mediator production by differential susceptibility to blockade using niridazole; pp. 4569–4572. (Proc. Nat. Acad. Sci. (USA)). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Paterson P.Y., Harvey J.M., Webster L.T. Niridazole suppression of experimental allergic encephalomyelitis (EAE) in Lewis rats. J. Immunol. 1977;118:2151–2154. [PubMed] [Google Scholar]
  • 26.Bernard C.C.A., Leydon J., MacKay I.R. Anti-T cell activity of niridazole in experimental autoimmune encephalomyelitis. Int. Arch. Allergy Appl. Immunol. 1977;53:555–559. doi: 10.1159/000231797. [DOI] [PubMed] [Google Scholar]
  • 27.Borel J.F., Feurer C., Gubler H.U., Stähelin H. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents & Actions. 1976;6:468–475. doi: 10.1007/BF01973261. [DOI] [PubMed] [Google Scholar]
  • 28.Green C.J., Allison A.C. Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin-A treatment. Lancet. 1978;I:1182–1183. doi: 10.1016/s0140-6736(78)90970-4. [DOI] [PubMed] [Google Scholar]
  • 29.Calne R.Y., White D.J.G., Rolles K., Smith D.P., Herbertson B.M. Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A. Lancet. 1978;I:1185. doi: 10.1016/s0140-6736(78)90971-6. [DOI] [PubMed] [Google Scholar]
  • 30.Boehme D.H., Umezawa H., Hashim G., Marks N. Treatment of experimental allergic encephalomyelitis with an inhibitor of cathepsin D (pepstatin) Neurochem. Res. 1978;3:185–194. doi: 10.1007/BF00964059. [DOI] [PubMed] [Google Scholar]
  • 1.Paterson P.Y. The demyelinating diseases, clinical and experimental studies in animals and man. In: Samter M., editor. Immunological Diseases. Little, Brown & Co; Boston: 1978. in press. [Google Scholar]
  • 2.Westall F.C., Lennon V.A., Gospodarowicz D. Vol. 75. 1978. Brain-derived fibroblast growth factor: identity with a fragment of the basic protein of myelin; pp. 4675–4678. (Proc. Natl. Acad. Sci. (USA)). (10) [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Molecular Aspects of Medicine are provided here courtesy of Elsevier

RESOURCES